{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:39:45Z","timestamp":1793014785191,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016017","name":"Duke-NUS Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vaccine.2025.127673","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:44:33Z","timestamp":1756795473000},"page":"127673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Robust evaluation of vaccine effects based on estimation of vaccine efficacy curve"],"prefix":"10.1016","volume":"63","author":[{"given":"Ziwei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Bun","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127673_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.vaccine.2025.127673_bb0010","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"10.1016\/j.vaccine.2025.127673_bb0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/sim.3783","article-title":"Estimation of intervention effects using first or multiple episodes in clinical trials: the Andersen-Gill model re-examined","volume":"29","author":"Cheung","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"S Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127673_bb0025","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJMoa2200674","article-title":"Safety and efficacy of a third dose of BNT162B2 covid-19 vaccine","volume":"386","author":"Moreira","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0030","article-title":"Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: a cluster randomized clinical trial","volume":"18","author":"Isanaka","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0035","series-title":"Survival analysis using SAS a practical guide","author":"Allison","year":"2010"},{"key":"10.1016\/j.vaccine.2025.127673_bb0040","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S1473-3099(22)00273-0","article-title":"Efficacy of RTS,S\/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5\u201317 months in Ghana and Kenya: An open-label, phase 2B","volume":"22","author":"Samuels","year":"2022","journal-title":"Randomised Controlled Trial Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127673_bb0045","article-title":"Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan","volume":"28","author":"Kayano","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2025.127673_bb0050","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4269\/ajtmh.22-0128","article-title":"Malaria in 2022: challenges and Progress","volume":"106","author":"Rosenthal","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.127673_bb0055","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4269\/ajtmh.22-0544a","article-title":"The importance of exercising caution when comparing results from malaria vaccines administered on the EPI schedule and on a seasonal schedule","volume":"107","author":"Birkett","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.127673_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00120-8","article-title":"COVID-19 vaccines: effectiveness and number needed to treat - authors\u2019 reply","volume":"2","author":"Olliaro","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2025.127673_bb0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1198\/016214502760046943","article-title":"Estimation of waning vaccine efficacy","volume":"97","author":"Kanaan","year":"2002","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2025.127673_bb0070","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/sim.7319","article-title":"Semiparametric estimation of time-varying intervention effects using recurrent event data","volume":"36","author":"Xu","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0075","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/sim.10049","article-title":"Estimation of trajectory of protective efficacy in infectious disease prevention trials using recurrent event times","volume":"43","author":"Cheung","year":"2024","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0080","article-title":"Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo","volume":"3","author":"Cairns","year":"2008","journal-title":"Ghana PLoS ONE"},{"key":"10.1016\/j.vaccine.2025.127673_bb0085","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on Covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2025.127673_bb0090","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/oxfordjournals.aje.a009385","article-title":"Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines","volume":"147","author":"Durham","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127673_bb0095","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1002\/sim.9001","article-title":"Assessing vaccine durability in randomized trials following placebo crossover","volume":"40","author":"Fintzi","year":"2021","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0100","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/cid\/ciab630","article-title":"Evaluating vaccine efficacy against SARS-CoV-2 infection","volume":"74","author":"Lin","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127673_bb0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/09622802241242325","article-title":"Methods for non-proportional hazards in clinical trials: a systematic review","volume":"33","author":"Bardo","year":"2024","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.vaccine.2025.127673_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ije\/13.1.87","article-title":"Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies","volume":"13","author":"Smith","year":"1984","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127673_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/15284336.2015.1123944","article-title":"Measuring the potential role of frailty in apparent declining efficacy of HIV interventions","volume":"16","author":"Hardnett","year":"2015","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.vaccine.2025.127673_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12874-017-0366-9","article-title":"A DAG-based comparison of interventional effect underestimation between composite endpoint and multi-state analysis in cardiovascular trials","volume":"17","author":"Jahn-Eimermacher","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"32","key":"10.1016\/j.vaccine.2025.127673_bb0125","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1016\/j.vaccine.2020.05.086","article-title":"Estimation of the primary, secondary and composite effects of malaria vaccines using data on multiple clinical malaria episodes","volume":"38","author":"Cheung","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127673_bb0130","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/sim.3623","article-title":"The estimation of average hazard ratios by weighted cox regression","volume":"28","author":"Schemper","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/nav.3800260304","article-title":"Simulation of nonhomogeneous Poisson processes by thinning","volume":"26","author":"Lewis","year":"1979","journal-title":"Naval Res Logist Q"},{"key":"10.1016\/j.vaccine.2025.127673_bb0140","article-title":"S Clinical Trials Partnership. Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: A phase 3 randomized, controlled trial in children and Young Infants at 11 African sites","volume":"11","author":"RTS","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2025.127673_bb0145","author":"Severe Malaria Observatory"},{"key":"10.1016\/j.vaccine.2025.127673_bb0155","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, r21 in adjuvant matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127673_bb0160","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2666-5247(21)00069-0","article-title":"COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room","volume":"2","author":"Olliaro","year":"2021","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127673_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00316-5","article-title":"Force of infection: A determinant of vaccine efficacy?","volume":"6","author":"Kaslow","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.127673_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00090-8","article-title":"The effect of disease transmission on time-aggregated treatment efficacy estimates: A critical analysis of factors influencing the RTS,S and R21 malaria vaccine phase 3 trials","author":"Maci\u00e0","year":"2025","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T03:53:30Z","timestamp":1765857210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25009703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"alternative-id":["S0264410X25009703"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127673","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust evaluation of vaccine effects based on estimation of vaccine efficacy curve","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127673"}}